EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
   3.5.3.18 | Hypertension, Pulmonary |
15827267 |
Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 3.5.3.18 | Kidney Failure, Chronic |
16025746 |
Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension. |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 3.5.3.18 | Coronary Artery Disease |
16144995 |
Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 3.5.3.18 | Cardiovascular Diseases |
16444868 |
DDAH gene and cardiovascular risk. |
causal interaction
diagnostic usage
unassigned |
4
2
0 |
| 3.5.3.18 | Hypertension |
16444868 |
DDAH gene and cardiovascular risk. |
causal interaction
diagnostic usage
unassigned |
4
2
0 |
| 3.5.3.18 | Pre-Eclampsia |
16508323 |
No Compensatory Upregulation of Placental Dimethylarginine Dimethylaminohydrolase Activity in Preeclampsia. |
causal interaction
unassigned |
2
0 |
| 3.5.3.18 | Cardiovascular Abnormalities |
16959216 |
Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction. |
causal interaction
unassigned |
3
0 |
| 3.5.3.18 | Spasm |
17164036 |
Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. |
causal interaction
unassigned |
3
0 |
| 3.5.3.18 | Atherosclerosis |
17293168 |
Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 3.5.3.18 | Hypercholesterolemia |
17293168 |
Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
